Up Front

Genetic Profiling for Personalized Cancer Care

Personalized medicine is a relatively new approach to disease management, but it’s still come a long way. Traditionally, features of a tumor were described based on its appearance under a microscope. Today, we know that the molecular profile of a tumor is critical. “The genetic makeup of a patient’s specific tumor can be used to guide healthcare practitioners in how best to treat an individual’s cancer,” ONS member Teresa Knoop, MSN, RN, AOCN®, CCRP, explains.

RE:Connect

A blog written by oncology nurses for oncology nurses

RE:Connect

Congress Doesn't End When You Leave

I am home from Congress, and it was a blast. The sessions that I attended were very informative, and being able to download the session recordings for concurrent or missed sessions is terrific. I also met with my special interest group (SIG), of which ONS has many. There are SIGs for surgical oncology, chemotherapy, different types of cancer, spiritual issues, and many more.

ONS News

ONS and ASCO Release Revised Chemotherapy Safety Standards

In 2011, a work­group con­sist­ing of Amer­i­can Soci­ety of Clin­i­cal Oncol­ogy (ASCO) and ONS mem­bers was con­vened to review feed­back received since pub­li­ca­tion of the ASCO/​​ONS Stan­dards for Safe Chemother­apy Admin­is­tra­tion in 2009 and to clar­ify the stan­dards as needed. The most sig­nif­i­cant change is the deci­sion to extend their scope to the inpa­tient set­ting. This [...]

Read more

Just In

Patients May Stop Taking Breast Cancer Drug Because of Side Effects

Researchers stud­ied 700 women who were being treated with aro­matase inhibitors and found that within four years, 36% of them had dropped out of treat­ment because of the side effects. One in every 10 patients stopped the treat­ment within 24 months. The side effects that caused the women to stop tak­ing their med­ica­tion included low­ered libido, weight gain, hot flashes, and severe pain in the joints.

Read more

Just In

Study Describes Changes in Children After a Sibling’s Death From Cancer

A new study has found that a major­ity of chil­dren expe­ri­ence pos­i­tive and neg­a­tive per­sonal and rela­tion­ship changes one year after their sib­ling has died from can­cer. The study is the first to exam­ine changes in chil­dren after the death of a brother or sis­ter from can­cer from three dif­fer­ent perspectives—mothers, fathers, and siblings—up to a year after the sib­ling has died.

Read more

Just In

HPV Test Detects Cervical Cancers Earlier Than Pap Test

Using a human papil­lo­mavirus test in con­junc­tion with a tra­di­tional Pap test results in ear­lier detec­tion of pre­can­cer­ous lesions than using a Pap test alone, accord­ing to a new study.

Read more

Just In

Radiation Not Warranted for Early-​​Stage Hodgkin Lymphoma

Patients with early-​​stage Hodgkin lym­phoma who were treated with mul­tidrug chemother­apy were more likely to be alive 12 years after treat­ment than patients who received the same chemother­apy plus radi­a­tion, accord­ing to a new study.

Read more

Advertisement
Advertisement